ReWalk Robotics Ltd
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended f… Read more
ReWalk Robotics Ltd (LFWD) - Net Assets
Latest net assets as of September 2025: $12.76 Million USD
Based on the latest financial reports, ReWalk Robotics Ltd (LFWD) has net assets worth $12.76 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($23.17 Million) and total liabilities ($10.41 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $12.76 Million |
| % of Total Assets | 55.05% |
| Annual Growth Rate | 10.86% |
| 5-Year Change | -72.35% |
| 10-Year Change | 74.85% |
| Growth Volatility | 155.04 |
ReWalk Robotics Ltd - Net Assets Trend (2016–2024)
This chart illustrates how ReWalk Robotics Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ReWalk Robotics Ltd (2016–2024)
The table below shows the annual net assets of ReWalk Robotics Ltd from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $18.85 Million | -59.47% |
| 2023-12-31 | $46.51 Million | 0.00% |
| 2023-09-30 | $46.51 Million | -31.77% |
| 2022-12-31 | $68.17 Million | 0.00% |
| 2022-09-30 | $68.17 Million | -23.74% |
| 2021-12-31 | $89.38 Million | 0.00% |
| 2021-09-30 | $89.38 Million | +310.50% |
| 2020-12-31 | $21.77 Million | 0.00% |
| 2020-09-30 | $21.77 Million | +101.99% |
| 2019-12-31 | $10.78 Million | +454.24% |
| 2018-12-31 | $1.95 Million | -47.53% |
| 2017-12-31 | $3.71 Million | -55.12% |
| 2016-12-31 | $8.26 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ReWalk Robotics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 15833300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.59 Million | 24.35% |
| Other Components | $279.08 Million | 1480.63% |
| Total Equity | $18.85 Million | 100.00% |
ReWalk Robotics Ltd Competitors by Market Cap
The table below lists competitors of ReWalk Robotics Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Neto Malinda
TA:NTML
|
$9.16 Million |
|
Green Hydrogen Systems AS
CO:GREENH
|
$9.16 Million |
|
Millcon Steel Public Company Limited
BK:MILL
|
$9.16 Million |
|
Empro Group Inc. Ordinary shares
NASDAQ:EMPG
|
$9.16 Million |
|
Lighthouse Capital Ltd
JSE:LTE
|
$9.15 Million |
|
Thomas Scott (India) Limited
NSE:THOMASCOTT
|
$9.15 Million |
|
Container Store Group Inc
NYSE:TCS
|
$9.15 Million |
|
PT Primadaya Plastisindo Tbk
JK:PDPP
|
$9.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ReWalk Robotics Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 46,510,000 to 18,849,000, a change of -27,661,000 (-59.5%).
- Net loss of 28,942,000 reduced equity.
- Other factors increased equity by 1,281,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-28.94 Million | -153.55% |
| Other Changes | $1.28 Million | +6.8% |
| Total Change | $- | -59.47% |
Book Value vs Market Value Analysis
This analysis compares ReWalk Robotics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.29x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.01x to 0.29x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $1316.81 | $7.56 | x |
| 2017-12-31 | $385.25 | $7.56 | x |
| 2018-12-31 | $111.00 | $7.56 | x |
| 2019-12-31 | $157.18 | $7.56 | x |
| 2020-12-31 | $116.06 | $7.56 | x |
| 2021-12-31 | $156.69 | $7.56 | x |
| 2022-12-31 | $91.83 | $7.56 | x |
| 2023-12-31 | $65.45 | $7.56 | x |
| 2024-12-31 | $26.04 | $7.56 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ReWalk Robotics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -153.55%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -112.78%
- • Asset Turnover: 0.84x
- • Equity Multiplier: 1.62x
- Recent ROE (-153.55%) is above the historical average (-291.40%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -393.50% | -553.81% | 0.18x | 3.85x | $-33.33 Million |
| 2017 | -666.77% | -318.81% | 0.34x | 6.17x | $-25.09 Million |
| 2018 | -1114.40% | -331.17% | 0.44x | 7.69x | $-21.87 Million |
| 2019 | -144.26% | -319.13% | 0.20x | 2.26x | $-16.63 Million |
| 2020 | -59.59% | -295.38% | 0.16x | 1.29x | $-15.15 Million |
| 2021 | -14.25% | -213.48% | 0.06x | 1.06x | $-21.67 Million |
| 2022 | -28.71% | -355.09% | 0.07x | 1.09x | $-26.39 Million |
| 2023 | -47.59% | -159.76% | 0.22x | 1.36x | $-26.78 Million |
| 2024 | -153.55% | -112.78% | 0.84x | 1.62x | $-30.83 Million |
Industry Comparison
This section compares ReWalk Robotics Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ReWalk Robotics Ltd (LFWD) | $12.76 Million | -393.50% | 0.82x | $9.15 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |